DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01801 INNOVENT BIO

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp.LargeCap Ind, HS Comp. L & M Index, HS China (HK) 100, Stock Connect HK Ind
Major Shareholders De-Chao Michael Yu (6.28%)
BlackRock, Inc. (5.15%)
Sector Health Care & Biotechnology
Web Site http://www.innoventbio.com Tel (86 512) 6956-6088
Email ir@innoventbio.com Fax (86 512) 6956-6088
Related Equities N/A
Principal Activities Principally engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical products, and provision of consultation and research and development services.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Pandanus Associates Inc. 173,351,060(L)  15.50(L)  31/10/2018
Pandanus Partners L.P. 173,351,060(L)  15.50(L)  31/10/2018
FMR LLC 156,245,560(L)  13.97(L)  31/10/2018
Johnson Abigail P. 156,245,560(L)  13.97(L)  31/10/2018
Johnson IV Edward C. 156,245,560(L)  13.97(L)  31/10/2018
Yu De-Chao Michael 145,728,230(L)  12.63(L)  27/11/2018
The Capital Group Companies, Inc. 78,277,090(L)  6.79(L)  27/11/2018
Temasek Holdings (Private) Limited 75,712,850(L)  6.77(L)  31/10/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Cooney Charles Leland 39,090(L)  0.00(L)  27/11/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top